Gender inequalities in secondary prevention of cardiovascular disease: a scoping review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gender inequalities in secondary prevention of cardiovascular disease: a scoping review ; volume:23 ; number:1 ; day:23 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
International journal for equity in health ; 23, Heft 1 (23.7.2024), 1-14, 12.2024
- Urheber
-
López Ferreruela, Irene
Obón Azuara, Blanca
Malo Fumanal, Sara
Rabanaque Hernández, María José
Aguilar-Palacio, Isabel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12939-024-02230-3
- URN
-
urn:nbn:de:101:1-2410272116270.193052065468
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- López Ferreruela, Irene
- Obón Azuara, Blanca
- Malo Fumanal, Sara
- Rabanaque Hernández, María José
- Aguilar-Palacio, Isabel
- SpringerLink (Online service)
Ähnliche Objekte (12)
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Smartphones in the secondary prevention of cardiovascular disease: a systematic review
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Prevention of cardiovascular diseases
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Cardiovascular risk prevention in children
PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Smartphones in the secondary prevention of cardiovascular disease: a systematic review
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Prevention of cardiovascular diseases
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Cardiovascular risk prevention in children
PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis
PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Smartphones in the secondary prevention of cardiovascular disease: a systematic review
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy
Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Prevention of cardiovascular diseases
Current Concepts: Comprehensive “Cardiovascular Health” Rehabilitation—An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases
Cardiovascular risk prevention in children